Literature DB >> 30745013

Fiducial placement for recurrent gastric cancer.

Mohamed M Abdelfatah1, Eric M Gochanour2.   

Abstract

A 53-year-old male was diagnosed with invasive adenocarcinoma of the pre-pyloric region. Imaging studies ruled out metastatic disease. The patient underwent neo-adjuvant chemotherapy followed by a partial gastrectomy. CT scan at 18 months' post-resection demonstrated right upper quadrant lesions suspicious for metastatic disease. EUS exam shows two round hypoechoic lesions. Fine needle aspiration with suction was performed with on-site cytology confirming malignant cells in the masses. Five gold fiducial markers were placed. Final pathology confirmed adenocarcinoma. The patient was subsequently started on stereotactic body radiation therapy (SBRT) with good results. This is the first case report EUS-guided fiducial markers for recurrent gastric cancer post-gastrectomy.
Copyright © 2019 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fiducial; Guided radiotherapy; Recurrent gastric cancer

Year:  2019        PMID: 30745013     DOI: 10.1016/j.ajg.2019.01.007

Source DB:  PubMed          Journal:  Arab J Gastroenterol        ISSN: 1687-1979            Impact factor:   2.076


  1 in total

1.  Neutrophil-to-lymphocyte ratio as a prognostic predictor for patients with cancer treated with stereotactic body radiation therapy: A meta-analysis.

Authors:  Yipin Yu; Duoting Tan; Can Liao; Pei Yang; Zhixi Hu; Hao Liang
Journal:  Mol Clin Oncol       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.